PACB News and Press, Pacific Biosciences of California Inc. From 11/03/21

New Pacific Biosciences of California (PACB) Q3 2021 Earnings Conference Call November 2, 2021 16:30 ET Company Participants Todd Friedman - Director of Investor Relations Christian Henry - President, Chief Executive Officer & Director Susan Kim - Chief Financial Officer Mark Van Oene - C...

Pacific Biosciences of California (NASDAQ:PACB) swung to a Q3 2021 gain of ~$16.5M from a $23.7M loss in the year-ago period thanks to a ~83% increase in net revenue to $34.9M. Total operating expenses also increased significantly -- 188% -- to 89.8M. Instrument revenue -- the company's ...

Pacific Biosciences of California (NASDAQ:PACB) is scheduled to announce Q3 earnings results on Tuesday, November 2nd, after market close. The consensus EPS Estimate is -$0.24 and the consensus Revenue Estimate is $33.6M (+76.1% Y/Y). Pacific Biosciences shares traded marginally lower de...

The genomic revolution is upon us, but you wouldn't know it just by looking at the share prices of these three stocks. Shares of Fulgent Genetics (NASDAQ: FLGT) , Amyris (NASDAQ: AMRS) , and Pacific Biosciences of California (NASDAQ: PACB) have been absolutely h...

MENLO PARK, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its third quarter 2021 financial results on Tuesday, November 2, 2021, at 4:30pm Eastern Time. The call will be webcast and m...

Baker Brothers’ 13F portfolio value decreased from $23.07B to $22.77B this quarter. The InVitae stake was reduced this quarter while increasing Apellis Pharma and Heron Therapeutics. The top three positions are Seagen, BeiGene, and Incyte Corporation and they add up to almo...

The following slide deck was published by Pacific Biosciences of California, Inc. in conjunction with this event. For further details see: Pacific Biosciences of California (PACB) Presents At 2021 Wells Fargo Virtual Healthcare Conference

MENLO PARK, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB)(“Pacific Biosciences” or “PacBio”), a leading provider of high-quality, highly accurate sequencing platforms, today announced a partnership with The ...

Omniome’s high accuracy short-read sequencing platform expected to significantly expand PacBio’s market opportunity Acquisition expected to accelerate the adoption of SMRT Sequencing, PacBio’s leading long-read sequencing platform PacBio also c...

Are These The Top Health Care Stocks To Watch This Week? While investors look for up-and-coming stocks in the stock market now, health care stocks continue to shine. After all, this sector of the market is home to countless companies looking to improve our overall quality of...